Crossref journal-article
Springer Science and Business Media LLC
Oncogene (297)
Bibliography

Patrawala, L., Calhoun, T., Schneider-Broussard, R., Li, H., Bhatia, B., Tang, S., Reilly, J. G., Chandra, D., Zhou, J., Claypool, K., Coghlan, L., & Tang, D. G. (2006). Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene, 25(12), 1696–1708.

Authors 12
  1. L Patrawala (first)
  2. T Calhoun (additional)
  3. R Schneider-Broussard (additional)
  4. H Li (additional)
  5. B Bhatia (additional)
  6. S Tang (additional)
  7. J G Reilly (additional)
  8. D Chandra (additional)
  9. J Zhou (additional)
  10. K Claypool (additional)
  11. L Coghlan (additional)
  12. D G Tang (additional)
References 39 Referenced 780
  1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF . (2003). Proc Natl Acad Sci USA 100: 3983–3988. (10.1073/pnas.0530291100)
  2. Beachy PA, Karhadkar SS, Berman DM . (2004). Nature 432: 324–331. (10.1038/nature03100)
  3. Bhatia B, Maldonado C, Tang S-H, Chandra D, Klein RD, Chopra D et al. (2003). J Biol Chem 278: 25091–25100. (10.1074/jbc.M301920200)
  4. Bhatia B, Tang S, Yang P, Doll A, Aumüeller G, Newman RA et al. (2005). Oncogene 24: 3583–3595. (10.1038/sj.onc.1208406)
  5. Bhatt RL, Brown MD, Hart CA, Gilmore P, Ramani VAC, George NJ et al. (2003). Cytometry 54A: 89–99. (10.1002/cyto.a.10058)
  6. Bonkhoff H, Stein U, Remberger K . (1994). Prostate 24: 42–46. (10.1016/0046-8177(94)90169-4)
  7. Chambers I, Smith A . (2004). Oncogene 23: 7150–7160. (10.1038/sj.onc.1207930)
  8. Collins AT, Habib FK, Maitland NJ, Neal DE . (2001). J Cell Sci 114: 3865–3872. (10.1242/jcs.114.21.3865)
  9. De Marzo AM, Bradshaw C, Sauvageot J, Epstein JI, Miller GJ . (1998). Prostate 34: 162–168. (10.1002/(SICI)1097-0045(19980215)34:3<162::AID-PROS2>3.0.CO;2-K)
  10. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ . (2004). Cancer Res 64: 5702–5711. (10.1158/0008-5472.CAN-04-0389)
  11. Gao AC, Lou W, Dong JT, Isaacs JT . (1997). Cancer Res 57: 846–849.
  12. Gao AC, Lou W, Sleeman JP, Isaacs JT . (1998). Cancer Res 58: 2350–2352.
  13. Garraway LA, Lin D, Signoretti S, Waltregny D, Dilks J, Bhattacharya N et al. (2003). Prostate 55: 206–218. (10.1002/pros.10244)
  14. Hudson DL, O'Hare M, Watt FM, Masters JRW . (2000). Lab Invest 80: 1243–1250. (10.1038/labinvest.3780132)
  15. Kallakury BV, Yang F, Figge J, Smith KE, Kausik SJ, Tacy NJ et al. (1996). Cancer 78: 1461–1469. (10.1002/(SICI)1097-0142(19961001)78:7<1461::AID-CNCR13>3.0.CO;2-Y)
  16. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H . (1990). J Clin Pathol 43: 213–219. (10.1136/jcp.43.3.213)
  17. Liu AY, True LD, LaTray L, Ellis WJ, Vessella RL, Lange PH et al. (1999). Prostate 40: 192–199. (10.1002/(SICI)1097-0045(19990801)40:3<192::AID-PROS7>3.0.CO;2-F)
  18. Liu AY, True LD, LaTray L, Nelson PS, Ellis WJ, Vessella RL et al. (1997). Proc Natl Acad Sci USA 94: 10705–10710. (10.1073/pnas.94.20.10705)
  19. Lokeshwar BL, Lokeshwar VB, Block NL . (1995). Anticancer Res 15: 1191–1198.
  20. Maitland NJ, Collins AT, Bryce S, Sarah M, Berry P, Hyde K et al. (2005). Proc Am Assoc Cancer Res, A2518.
  21. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT et al. (1992). Cancer Res 52: 6940–6944.
  22. Nagabhushan M, Pretlow TG, Guo YJ, Amini SB, Pretlow TP, Sy MS . (1996). Am J Clin Pathol 106: 647–651. (10.1093/ajcp/106.5.647)
  23. Noordzij MA, van Steenbrugge GJ, Schroder FH, van der Kwast TH . (1999). Int J Cancer 84: 478–483. (10.1002/(SICI)1097-0215(19991022)84:5<478::AID-IJC5>3.0.CO;2-N)
  24. Omara-Opyene AL, Qiu J, Shah GV, Iczkowski KA . (2004). Lab Invest 84: 894–907. (10.1038/labinvest.3700112)
  25. Paradis V, Eschwege P, Loric S, Dumas F, Ba N, Benoit G et al. (1998). J Clin Pathol 51: 798–802. (10.1136/jcp.51.11.798)
  26. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG . (2005). Cancer Res 65: 6207–6219. (10.1158/0008-5472.CAN-05-0592)
  27. Ponta H, Sherman L, Herrlich PA . (2003). Nat Rev Mol Cell Biol 4: 33–45. (10.1038/nrm1004)
  28. Reiter RE, Sawyers CL . (2001). In: Chung LWK, Isaacs WB, Simons JW (eds). Prostate Cancer: Biology, Genetics, and the New Therapeutics. Humana Press Inc.: Totowa, NJ, pp 163–174. / Prostate Cancer: Biology, Genetics, and the New Therapeutics by RE Reiter (2001)
  29. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT . (2004). J Cell Sci 117: 3539–3545. (10.1242/jcs.01222)
  30. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L et al. (2000). Am J Pathol 157: 1769–1775. (10.1016/S0002-9440(10)64814-6)
  31. Tai MH, Chang CC, Olson LK, Trosko JE . (2005). Carcinogenesis 26: 495–502. (10.1093/carcin/bgh321)
  32. Tang S, Bhatia B, Maldonado C, Yang P, Newman RA, Liu J et al. (2002). J Biol Chem 277: 16189–16201. (10.1074/jbc.M111936200)
  33. Tran CP, Lin C, Yamashiro J, Reiter RE . (2002). Mol Cancer Res 1: 113–121.
  34. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M et al. (2004). Science 303: 359–363. (10.1126/science.1092436)
  35. Valk-Lingbeek ME, Bruggeman SWM, van Lohuizen M . (2004). Cell 118: 409–418. (10.1016/j.cell.2004.08.005)
  36. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL et al. (2003). Prostate 57: 205–225. (10.1002/pros.10290)
  37. van Leenders G, Dijkman H, van de Kaa H, Ruiter D, Schalken J . (2000). Lab Invest 80: 1251–1258. (10.1038/labinvest.3780133)
  38. Wang Y, Hayward SW, Cao M, Thayer KA, Cunha GR . (2001). Differentiation 68: 270–279. (10.1046/j.1432-0436.2001.680414.x)
  39. Yardy GW, Brewster SF . (2005). Prostate Cancer Prostatic Dis 8: 119–126. (10.1038/sj.pcan.4500794)
Dates
Type When
Created 19 years, 7 months ago (Jan. 31, 2006, 10:53 a.m.)
Deposited 3 years, 5 months ago (March 22, 2022, 4:37 a.m.)
Indexed 3 days, 5 hours ago (Aug. 29, 2025, 6:40 a.m.)
Issued 19 years, 7 months ago (Jan. 30, 2006)
Published 19 years, 7 months ago (Jan. 30, 2006)
Published Online 19 years, 7 months ago (Jan. 30, 2006)
Published Print 19 years, 5 months ago (March 16, 2006)
Funders 0

None

@article{Patrawala_2006, title={Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells}, volume={25}, ISSN={1476-5594}, url={http://dx.doi.org/10.1038/sj.onc.1209327}, DOI={10.1038/sj.onc.1209327}, number={12}, journal={Oncogene}, publisher={Springer Science and Business Media LLC}, author={Patrawala, L and Calhoun, T and Schneider-Broussard, R and Li, H and Bhatia, B and Tang, S and Reilly, J G and Chandra, D and Zhou, J and Claypool, K and Coghlan, L and Tang, D G}, year={2006}, month=jan, pages={1696–1708} }